Search & Analyze
Popular Searches
Piramal Pharma Ltd.
Healthcare₹181.651.54%
24 Jul, 4:01 PM
CMP₹181.65
Mkt Cap₹24.08K Cr
P/E0.00
P/B2.97
ROE1.14%
52W High₹210.35
52W Low₹132.50
Customise metrics bar
Stock DNA
Key Ratios
P/B Ratio
2.97
EV/EBITDA
24.98
Price/Sales
2.71
Dividend Yield (%)
0.00
EPS (TTM ₹)
-2.45
Book Value (₹)
60.80
ROE (%)
1.14
ROCE (%)
6.61
ROA (%)
0.60
EBITDA Margin (%)
13.35
Net Profit Margin (%)
0.86
Debt/Equity
0.59
Current Ratio
1.53
Interest Coverage
1.98
Asset Turnover
0.70
Working Capital/Sales
5.23
Core EBITDA Growth (%)
15.16
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 6559.1 | 7081.55 | 8171.16 | 9151.18 | 8869.08 |
| Net Sales | 6559.1 | 7081.55 | 8171.16 | 9151.18 | 8869.08 |
| Total Income | 6834.9 | 7306.66 | 8372.3 | 9312.95 | 9111.51 |
| Total Expenditure | 5609.44 | 6453.31 | 7000.65 | 7733.31 | 7976.59 |
| Operating Profit | 1225.46 | 853.35 | 1371.65 | 1579.64 | 1134.92 |
| Depreciation | 586.18 | 676.69 | 740.57 | 816.34 | 831.24 |
| Exceptional Items | -15.08 | -6.96 | -62.79 | — | -196.14 |
| Profit Before Tax | 484.98 | -120.15 | 179.29 | 414.64 | -176.06 |
| Tax | 109.02 | 66.31 | 161.47 | 323.51 | 149.88 |
| Profit After Tax (PAT) | 375.96 | -186.46 | 17.82 | 91.13 | -325.94 |
| EPS (₹) | 3.19 | -1.54 | 0.14 | 0.69 | -2.46 |
| Dividend Payout % | — | — | 1.1 | 1.4 | — |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1185.91 | 1193.32 | 1322.95 | 1324.35 | 1327.16 |
| Reserves | 5510.69 | 5580.18 | 6560.95 | 6738.96 | 6762.67 |
| Shareholders Funds | 6696.6 | 6773.5 | 7911.37 | 8125.47 | 8162.62 |
| Total Debt | 4023.28 | 5504.77 | 4558.86 | 4720.27 | 5495.48 |
| Total Liabilities | 12717.19 | 14436.54 | 14925.31 | 15284.46 | 17566.77 |
| Total Assets | 12717.19 | 14436.54 | 14925.31 | 15284.46 | 17566.77 |
| Book Value / Share | 56.468 | 56.7618 | 59.5933 | 60.885 | 60.956 |
| Assets | 12717.19 | 14436.54 | 14925.31 | 15284.46 | 17566.77 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 766.42 | 483.89 | 1004.54 | 892.3 | 1652.6 |
| Investing Activities | -1812.1 | -1338.78 | -434.01 | -477.46 | -826.03 |
| Financing Activities | 794.19 | 817.79 | -422.36 | -440.83 | -38.98 |
| Net Cash Flow | -251.49 | -37.1 | 148.17 | -25.99 | 787.59 |
PPLPHARMA
₹181.65
+1.54%